Farnier M, Kastelein JJP. European Physicians’ Perspectives on Cholesterol Management and Inhibition of Cholesterol Absorption and Production. European Cardiovascular Disease 2007.

Excerpt link:


“Clinical trial evidence from the past two decades has demonstrated that lowering cholesterol levels markedly impacts the occurrence of cardiovascular (CV) disease, including coronary heart disease, a leading cause of mortality and morbidity in the US and Europe.1-7 Data from these studies form the basis of national and international treatment guidelines delineating lipid thresholds and recommending treatment goals for a variety of patient types.8-11 These guidelines are an important management tool to help physicians reduce the impact of atherosclerotic-related CV disease in clinical practice….”